New Study Validates LINX® as a Preferred New Treatment for Gastroesophageal Reflux Disease
Bioportfolio,
ST. PAUL, Minn., Dec. 1, 2015 /PRNewswire/ -- Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related…
Torax Medical Release New Study Validates LINX As A Preferred New Treatment For Gastroesophageal Reflux Disease
Device Space,
ST. PAUL, Minn., Dec. 1, 2015 /PRNewswire/ -- Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related…
Torax Medical Release: New Study Validates LINX As A Preferred New Treatment For Gastroesophageal Reflux Disease
Biospace,
ST. PAUL, Minn., Dec. 1, 2015 /PRNewswire/ -- Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related…